Stephen M Simes's Net Worth
$15.6 Million
Who is Stephen M Simes?
Stephen M Simes has an estimated net worth of $15.6 Million. This is based on reported shares across multiple companies, which include RestorGenex Corp, BIOSANTE PHARMACEUTICALS INC, and CytoDyn Inc..
SEC CIK
Stephen M Simes's CIK is 0000905479
Past Insider Trading and Trends
2004 was Stephen M Simes's most active year for acquiring shares with 3 total transactions. Stephen M Simes's most active month to acquire stocks was the month of December. 2004 was Stephen M Simes's most active year for disposing of shares, totalling 8 transactions. Stephen M Simes's most active month to dispose stocks was the month of February. 2004 saw Stephen M Simes paying a total of $477,500.70 for 199,167 shares, this is the most they've acquired in one year. In 2004 Stephen M Simes cashed out on 272,343 shares for a total of $1,192,501.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RestorGenex Corp (CRVO) Snapshot price: $8.39
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOSANTE PHARMACEUTICALS INC (ANIP) Snapshot price: $56.225
Vice Chairman, President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +2.54% | 5K |
$1.77 | $8,848.50 | 202.17K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +5.34% | 10K |
$1.09 | $10,900.00 | 197.17K |
Jan 2
| |||
Form 4
| +0.27% | 500 |
$2.15 | $1,075.00 | 187.07K |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
| +5.66% | 10K |
$3.70 | $37,000.00 | 186.57K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| +57.84% | 40.2K |
$3.07 | -$1.74 | 109.69K |
Mar 27
| |||
Form 4
| -9.07% | -6.67K |
$6.53 | -$503,503.48 | 66.88K |
Nov 30
| |||
Form 4
| -0.93% | -650.00 |
—
|
—
| 69.49K |
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +10.46% | 6.64K |
$4.70 | $2.40 | 70.14K |
Feb 5
| |||
Form 4
| +1.60% | 1K |
$2.15 | $2,150.00 | 63.5K |
Aug 4
| |||
| No matching records found | |||||||||
CytoDyn Inc. (CYDY) Snapshot price: $0.1599
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||